BrainAurora Medical Technology Limited has announced that its board of directors will convene on 28 August 2026 to review and approve the Group’s interim financial results for the six months ended 30 June 2026. The meeting will also address related matters and authorise the publication of the interim report.
The announcement, dated 18 August 2026, confirms the company’s current board composition: one executive director (Chairman Tan Zheng), three non-executive directors (Deng Feng, Yang Fan and Wang Jingbo) and three independent non-executive directors (Lam Yiu Por, Dr. Duan Tao and Tu Lei).
Investors will gain clarity on BrainAurora’s half-year performance following the board’s deliberations and subsequent release of the interim results.